Patients diagnosed with Immune Thrombocytopenic Purpura (ITP)
QSC304171 group 1
Overview
This study is for patients diagnosed with Immune Thrombocytopenic Purpura (ITP).
This study is to look at how well a new test medicine is tolerated when given by injection.
The test medicine has been taken by people before.
Please note: Information correct at time of publishing but may be subject to final Ethics or MHRA approval and may change without notice. E&OE.
Payment
£7,675
plus travel allowances
Volunteer profile
- Males and Females
- Aged 18 - 80
- BMI 17.5 - 35
Schedule information
1
Screening Visit
Various Dates Available
An appointment with a doctor & nurse lasting approx. 4 hours
2
Residential Visit - Admission AM - Discharge AM
Wednesday 9th September - Tuesday 15th September
6 night stay in our unit
3
5 x Outpatient Dose
Sunday 20th September, Thursday 24th September, Sunday 27th September, Thursday 1st October, Sunday 4th October
Outpatient Dose x 5
4
Return Visits x 4
Tuesday 6th October, Thursday 8th October, Monday 12th October, Thursday 15th October
A appointment with a doctor & nurse lasting up to an hour
5
Follow up Visit
Tuesday 27th October
An appointment appointment with a doctor & nurse
6
Follow up Call
Tuesday 3rd November
A Telephone appointment with a Doctor and Nurse